Design, synthesis and study of small molecules with both AR degradation and AKR1C3 inhibitory activities

被引：0
|
作者：
Xing, Enming [1 ]
Kong, Xiaotian [1 ]
Lou, Wei [2 ]
Shi, Ruihua [1 ]
Cheng, Xiaolin [1 ]
Gao, Allen C. [2 ]
Li, Pui Kai [1 ]
机构：
[1] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
[2] Univ Calif Davis, Davis, CA 95616 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5681
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5681
引用
收藏
页数：2
相关论文
共 50 条
  • [21] AKR1C3 Expression in Non-small Cell Lung Cancer as a Predictor for Radiotherapeutic Sensitivity
    Song, X.
    Xie, L.
    Wang, X.
    Wei, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S665 - S665
  • [22] NOVEL FUNCTION OF PTUPB IN AKR1C3/AR/AR-V7 AXIS INHIBITION AND ENZALUTAMIDE SENSITIZATION IN ADVANCED PROSTATE CANCER
    Yang, Joy
    Xu, Pengfei
    Chen, Bo
    Ning, Shu
    Adomat, Hans
    Hwang, Sung-Hee
    Gao, Allen
    Gleave, Martin
    Hammock, Bruce
    Evans, Christopher
    Liu, Chengfei
    JOURNAL OF UROLOGY, 2023, 209 : E281 - E282
  • [23] AKR1C3 and β-catenin expression in non-small cell lung cancer and relationship with radiation resistance
    Xiong, Wei
    Huang, Xiaozhi
    Hue, Wanning
    JOURNAL OF BUON, 2021, 26 (03): : 802 - 811
  • [24] AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer
    Liu, Chengfei
    Yang, Joy C.
    Armstrong, Cameron M.
    Lou, Wei
    Liu, Liangren
    Qiu, Xiaomin
    Zou, Binhao
    Lombard, Alan P.
    D'Abronzo, Leandro S.
    Evans, Christopher P.
    Gao, Allen C.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1875 - 1886
  • [25] Discovery of dual-functional AKR1C3 inhibitors and AR antagonists as a novel treatment for castration resistant prostate cancer
    Wangtrakuldee, Phumvadee
    Adeniji, Adegoke
    Tamae, Daniel
    Zang, Tianzhu
    Twenter, Barry
    Estrada, Michelle
    Winkler, Jeffrey
    Penning, Trevor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [26] Structure-function aspects and inhibitor design of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)
    Penning, TM
    Burczynski, ME
    Jez, JM
    Lin, HK
    Ma, HC
    Moore, M
    Ratnam, K
    Palackal, N
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 171 (1-2) : 137 - 149
  • [27] Design, synthesis, and biological evaluation of flufenamic acid derived bioisosteres as inhibitors of aldo- keto reductase 1C3 (AKR1C3) expressed in prostate cancer
    Lolli, Marco
    Cena, Clara
    Giraudo, Alessandro
    Marini, Elisabetta
    Pippione, Agnese
    Oliaro-Bosso, Simonetta
    Ferrante, Terenzio
    Sadiq, Maria
    Pors, Klaus
    Boschi, Donatella
    Braga, Rudolpho
    Andrade, Carolina
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [28] Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer
    Park, Sulgi
    Song, Chung-Seog
    Lin, Chun-Lin
    Jiang, Shoulei
    Osmulski, Pawel A.
    Wang, Chiou-Miin
    Marck, Brett T.
    Matsumoto, Alvin M.
    Morrissey, Colm
    Gaczynska, Maria E.
    Chen, Yidong
    Mostaghel, Elahe A.
    Chatterjee, Bandana
    ENDOCRINOLOGY, 2020, 161 (02)
  • [29] The AKR1C3/AR-V7 complex maintains CRPC tumour growth by repressing B4GALT1 expression
    Wang, Bin
    Wu, Shiqi
    Fang, Yong
    Sun, Guangxi
    He, Dalin
    Hsieh, Jer-Tsong
    Wang, Xinyang
    Zeng, Hao
    Wu, Kaijie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (20) : 12032 - 12043
  • [30] In silico study of novel alpha tocopheroids as effective inhibitors of aldo-keto reductase 1c3 (AKR1C3) enzyme
    Basu, Tanmayee
    Upadhyay, Atul Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (15): : 7715 - 7729
12345